Commonwealth Equity Services
TNDM icon

Commonwealth Equity Services’s Tandem Diabetes Care TNDM Stock Holding History

Commonwealth Equity Services’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,740
Closed -$243K – 4285
2024
Q4 		$243K Sell
6,740
-1,417
-17% -$47.9K ﹤0.01% 3598
2024
Q3 		$346K Sell
8,157
-261
-3% -$11.1K ﹤0.01% 3224
2024
Q2 		$339K Buy
8,418
+228
+3% +$9.51K ﹤0.01% 3192
2024
Q1 		$290K Buy
8,190
+483
+6% +$12.9K ﹤0.01% 3311
2023
Q4 		$228K Sell
7,707
-2,163
-22% -$44.9K ﹤0.01% 3403
2023
Q3 		$205K Buy
9,870
+908
+10% +$24.9K ﹤0.01% 3362
2023
Q2 		$220K Sell
8,962
-873
-9% -$28.1K ﹤0.01% 3326
2023
Q1 		$399 Buy
9,835
+91
+0.9% +$3.77K ﹤0.01% 2740
2022
Q4 		$437K Sell
9,744
-2,519
-21% -$114K ﹤0.01% 2580
2022
Q3 		$586K Buy
12,263
+1,117
+10% +$61.2K ﹤0.01% 2266
2022
Q2 		$659K Buy
11,146
+1,312
+13% +$108K ﹤0.01% 2214
2022
Q1 		$1.14M Sell
9,834
-90
-0.9% -$10.5K ﹤0.01% 1891
2021
Q4 		$1.49M Buy
9,924
+137
+1% +$18.5K ﹤0.01% 1695
2021
Q3 		$1.17M Buy
9,787
+503
+5% +$55.4K ﹤0.01% 1804
2021
Q2 		$904K Buy
9,284
+2,409
+35% +$215K ﹤0.01% 1986
2021
Q1 		$606K Sell
6,875
-1,373
-17% -$128K ﹤0.01% 2172
2020
Q4 		$789K Buy
8,248
+113
+1% +$11.6K ﹤0.01% 1813
2020
Q3 		$923K Buy
8,135
+1,270
+18% +$133K ﹤0.01% 1544
2020
Q2 		$679K Sell
6,865
-4,354
-39% -$347K ﹤0.01% 1669
2020
Q1 		$721K Buy
11,219
+2,920
+35% +$205K ﹤0.01% 1455
2019
Q4 		$494K Sell
8,299
-978
-11% -$60.3K ﹤0.01% 1916
2019
Q3 		$547K Buy
9,277
+3,527
+61% +$225K ﹤0.01% 1760
2019
Q2 		$370K Sell
5,750
-6,788
-54% -$438K ﹤0.01% 2035
2019
Q1 		$796K Sell
12,538
-6,345
-34% -$333K ﹤0.01% 1453
2018
Q4 		$716K Buy
18,883
+1,364
+8% +$48.2K ﹤0.01% 1402
2018
Q3 		$750K Buy
+17,519
New +$612K ﹤0.01% 1504
2017
Q4 		– Sell
-1,611
Closed -$12K – 2719
2017
Q3 		$12K Buy
+1,611
New +$10.2K ﹤0.01% 2550

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services's TNDM Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 6,740 shares — an estimated $243K sold.

Commonwealth Equity Services first reported a position in TNDM in Q3 2017 and held it in 27 quarters. The position peaked at $1.49M in Q4 2021. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Commonwealth Equity Services reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 6,740 Tandem Diabetes Care shares in Q1 2025, an estimated $243K.
  • Commonwealth Equity Services first reported a position in Tandem Diabetes Care in Q3 2017 and held it in 27 quarters.
  • Commonwealth Equity Services's Tandem Diabetes Care position peaked at $1.49M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.